Biological Software is one or more synthetic molecules that execute complex functions, specified from a program, in a biological system. We are creating tools to develop increasingly powerful biological software for the rational design of novel, broadly accessible medicines and biotechnologies previously out of reach. Our antedisciplinary team of scientists, machine learning researchers, engineers and entrepreneurs is growing. If you are excited to learn, teach, discover, and create together in pursuit of learning life's languages to improve the lives of billions of people around the world, please visit our website.
$100M sweet spot round size
2021
$100M
from 3 investors over 1 rounds
Inceptive raised $100M on October 7, 2023
Investors: Andreessen Horowitz, NVIDIA and + 2 Other investors